A shared genetic contribution to breast cancer and schizophreniaShow others and affiliations
2020 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 11, no 1, article id 4637Article in journal (Refereed) Published
Abstract [en]
An association between schizophrenia and subsequent breast cancer has been suggested; however the risk of schizophrenia following a breast cancer is unknown. Moreover, the driving forces of the link are largely unclear. Here, we report the phenotypic and genetic positive associations of schizophrenia with breast cancer and vice versa, based on a Swedish population-based cohort and GWAS data from international consortia. We observe a genetic correlation of 0.14 (95% CI 0.09-0.19) and identify a shared locus at 19p13 (GATAD2A) associated with risks of breast cancer and schizophrenia. The epidemiological bidirectional association between breast cancer and schizophrenia may partly be explained by the genetic overlap between the two phenotypes and, hence, shared biological mechanisms.
Place, publisher, year, edition, pages
Nature Publishing Group, 2020. Vol. 11, no 1, article id 4637
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-85862DOI: 10.1038/s41467-020-18492-8ISI: 000607162200003PubMedID: 32934226Scopus ID: 2-s2.0-85091054813OAI: oai:DiVA.org:oru-85862DiVA, id: diva2:1470027
Funder
The Karolinska Institutet's Research Foundation2020-09-232020-09-232023-03-28Bibliographically approved